General Information of the Compound
| Compound ID |
CP0379809
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-hydroxy-7-[(1R)-1-hydroxy-2-[2-[4-(2-methylpropyl)phenyl]ethylamino]ethyl]-3H-1,3-benzothiazol-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H26N2O3S
|
||||||||||||||||||
| Molecular Weight |
386.517
|
||||||||||||||||||
| Canonical SMILES |
CC(C)Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H26N2O3S/c1-13(2)11-15-5-3-14(4-6-15)9-10-22-12-18(25)16-7-8-17(24)19-20(16)27-21(26)23-19/h3-8,13,18,22,24-25H,9-12H2,1-2H3,(H,23,26)/t18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WNDBXZVUUVHVNV-SFHVURJKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT00943, D(3) dopamine receptor